EN DE

Laurel Organics Ltd (530313) Fair Value & Analysis

Other · IN · Market cap ₹1.4B

LO Laurel Organics Ltd 530313 · BSE
Price₹28.17
Fair Value₹34.54
Upside+22.6%
Quality71/100
Watch Laurel Organics Ltd for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 0.0% net margin
High debt
Ranks above peers (8/10)
Evidence: High Range ₹25.90 – ₹43.17 Share as image

Fair value as of: Aug 13, 2026

From 24 valuation models · updated 5 days ago

A solid business, screening 23% undervalued on our models.

What matters now

  • Our model range runs from ₹25.90 (bear) to ₹43.17 (bull), base ₹34.54. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 71/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹80.78 ₹23.55 Fair Value ₹34.54 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹23.55 – ₹80.78 · fair‑value band ₹25.90 – ₹43.17 · the ₹28.17 price screens below the ₹34.54 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Laurel Organics Ltd (530313) currently trades at ₹28.17, while our model-based Fair Value estimate is ₹34.54, implying the stock looks roughly 22.6% undervalued today. The Quality Score stands at 71/100 (solid quality), in the Other sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

The stock trades on a trailing P/E of 55.9 (as of Jul 4, 2026). Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹25.90 (bear case) to ₹43.17 (bull case); at ₹28.17, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 62% below its 52-week high and 21% above its 52-week low. For context, the median of 10 Other peers we cover trades at -24% fair-value upside, at 23%, 530313 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹39.07 ₹69.68 ₹117.78 80
Rev-Margin DCF ₹32.88 ₹58.50 ₹112.25 74
ROIC Compounder ₹25.59 ₹35.78 ₹47.54 72
All 24 models by family
DCF Models
FCF DCF ₹41.90 ₹62.53 ₹124.16 38
Owner Earnings ₹18.13 ₹40.74 ₹82.70 31
5Y Revenue Exit ₹29.66 ₹50.75 ₹94.67 39
5Y EBITDA Exit ₹32.12 ₹55.73 ₹101.87 41
5Y P/E Exit ₹28.13 ₹59.47 ₹100.98 38
10Y Revenue Exit ₹33.03 ₹69.04 ₹89.94 36
10Y EBITDA Exit ₹35.60 ₹73.87 ₹137.86 37
10Y P/E Exit ₹32.94 ₹66.04 ₹117.70 35
Earnings-Based
Graham-Dodd ₹12.89 ₹89.87 ₹126.12 54
Lynch FV ₹46.43 ₹66.33 ₹86.23 50
PEG = 1.0 ₹46.43 ₹66.33 ₹86.23 46
EPV ₹20.99 ₹24.26 ₹26.98 59
Multiples
P/E Multiple ₹24.16 ₹32.22 ₹40.27 63
P/S Multiple ₹24.16 ₹32.22 ₹40.27 58
P/B Multiple ₹4.42 ₹5.89 ₹7.37 55
EV/EBIT ₹31.97 ₹43.61 ₹55.25 53
EV/EBITDA ₹26.99 ₹36.97 ₹46.95 54
EV/Revenue ₹21.66 ₹32.21 ₹42.76 43
Asset-Based
NCAV (Graham) ₹0.9800 ₹1.32 ₹1.96 50
Growth DCF
Growth DCF ₹39.07 ₹69.68 ₹117.78 80
Rev-Margin DCF ₹32.88 ₹58.50 ₹112.25 74
Economic Profit
Residual Income ₹9.90 ₹16.96 ₹375.89 61
ROIC Compounder ₹25.59 ₹35.78 ₹47.54 72
Growth Earnings
Growth-Adj P/E ₹57.12 ₹81.60 ₹106.08 68

Widest divergence: Growth Earnings (₹81.60) versus Asset-Based (₹1.32). Highest evidence: Growth DCF (80).

Notify me when 530313 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Quality Score breakdown

Overall quality 71/100

Of which business quality 66 · Market factors (momentum, volatility) 7

Profitability 70
Margins and returns on capital today
Quality Growth 80
Are margins and returns improving?
Cashflow 79
Earnings quality: real cash, not paper profit
Fin. Strength 14
Balance sheet, leverage, solvency risk
Investment 96
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 12
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India. The company offers Benfotiamine, Cilnidipine, Gliclazide, Levosulpride, Rosuvastatin Calcium, Tranexamic Acid, Benidipine, Teneligliptin Hydrate Hydrobromide, Acotiamide, Citicoline Sodium, Luliconazole, Deflazacort, Voglibose, Oxaceprol, Ursodeoxycholic Acid, Bacitracin Zinc, …

Full company description

Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India. The company offers Benfotiamine, Cilnidipine, Gliclazide, Levosulpride, Rosuvastatin Calcium, Tranexamic Acid, Benidipine, Teneligliptin Hydrate Hydrobromide, Acotiamide, Citicoline Sodium, Luliconazole, Deflazacort, Voglibose, Oxaceprol, Ursodeoxycholic Acid, Bacitracin Zinc, Isotretinoin, and Tretinoin, as well as vitamin B1, calcium channel blocker, central stimulant/nootropic agent, and choleretic agent. It also provides products for various therapeutic categories, which comprise antidiabetic, antipsychotic, antihyperlipidemic, hemostatic, antihypertensive, antidiabetic, antiemetic, anti-fungal, anti-inflammatory, and anti-acne. The company was incorporated in 1993 and is based in New Delhi, India. Laurel Organics Ltd is a subsidiary of Kimia Biosciences Ltd.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Laurel Organics Ltd reported revenue of ₹1.2B in FY2025 versus ₹1.3B in FY2021, a compound −2.7%/yr. Reported net income was ₹96.1M in FY2025, compounding +17.1%/yr from FY2021.

Growth Quality 54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
₹1.2B
Latest YoY
+13.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.3%
Avg. growth/yr (11Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+30.3%
Revenue −2.7%/yr
FY21 ₹1.3B
FY22 ₹1.2B
FY23 ₹1.3B
FY24 ₹1.0B
FY25 ₹1.2B
Net income +17.1%/yr
FY21 ₹51.0M
FY22 −₹37.0M
FY23 −₹93.5M
FY24 −₹53.1M
FY25 ₹96.1M

Watch 530313: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Laurel Organics Ltd Fair Value". https://www.fairvalue-calculator.com/stock/530313

Peer Group

Other · 373 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 71 · Top 25%
Fair Value upside +23% · Above median
Return on assets 0% · Top 25%
Net margin (TTM) 0% · Above median
Operating margin (TTM) 0% · Above median
Revenue growth 0% · Top 25%
Debt / equity 1.53× · Higher than 75% of peers

Valuation Multiples vs Other median · lower = cheaper

P/E (TTM) 55.9× · Pricier than 75% of peers
P/B 0.15× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 63 · sector 9
FUTURE 0 · sector 0
PAST 0 · sector 0
HEALTH 24 · sector 97
DIVIDEND 0 · sector 31

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Other stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Federal Home Loan Mortgage Corporation FREJO $15.58 $51.90 +233%
533278 533278 ₹409.15 ₹660.78 +62%
Nestl?? India Limited 500790 ₹1,497 ₹191.93 -87%
ITC Limited 500875 ₹279.50 ₹212.74 -24%
Wipro Limited 507685 ₹183.80 ₹193.38 +5%
540376 540376 ₹4,054 ₹1,542 -62%
540777 540777 ₹537.50 ₹149.72 -72%
Lupin Limited 500257 ₹2,265 ₹1,983 -12%
Dabur India Limited 500096 ₹413.80 ₹122.93 -70%
540719 540719 ₹1,835 ₹872.41 -52%

Compare Laurel Organics Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Laurel Organics Ltd (530313) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹34.54 versus a price of ₹28.17, about +23% (undervalued).
What is the fair value of 530313?
Our model-based fair value for Laurel Organics Ltd is ₹34.54 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹28.17.
What is the quality score of 530313?
Laurel Organics Ltd has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of 530313?
The net profit margin of Laurel Organics Ltd is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Laurel Organics Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.